SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018934
Filing Date
2016-05-10
Accepted
2016-05-10 16:06:22
Documents
50
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20160331.htm 10-Q 1302497
2 EX-10.18 cala-ex1018_206.htm EX-10.18 94965
3 EX-31.1 cala-ex311_7.htm EX-31.1 13920
4 EX-31.2 cala-ex312_9.htm EX-31.2 13883
5 EX-32.1 cala-ex321_6.htm EX-32.1 6702
6 EX-32.2 cala-ex322_8.htm EX-32.2 6933
7 GRAPHIC gwa32fi11ksa000010.jpg GRAPHIC 63802
8 GRAPHIC gwa32fi11ksa000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-16-018934.txt   4540363

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cala-20160331.xml EX-101.INS 1015180
10 XBRL TAXONOMY EXTENSION SCHEMA cala-20160331.xsd EX-101.SCH 26153
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20160331_cal.xml EX-101.CAL 28915
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20160331_def.xml EX-101.DEF 55694
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20160331_lab.xml EX-101.LAB 193457
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20160331_pre.xml EX-101.PRE 144085
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 161635780
SIC: 2834 Pharmaceutical Preparations